Replies to post #105531 on Amarin Corp Plc (AMRN)

[Webster_iam]

JL, i had a thought regarding the 80% IA completion. If the RRR is > 20 percent, possibly in the 30 to 40 range, is there any obligation on AMRN's part to inform placebo patients due to liability exposure? Not sure of the contract for RI enrollees, but one would think they deserve to have some option to jump to V if during the IA, the DMC sees stellar efficacy. Would liability exposure have any impact on AMRN's decision to halt vs continue in June/July?

[Whalatane]

Agree with your post .
So how do you see AMRN getting to final R-IT read out without a capital raise ...or do you expect a capital raise ( or licensing deal ) ..?

COH was $96m , losing about $20m a Qt ...doubt if they will let COH fall below $50m ....

I'm wondering if or when we will see a bump in expenses related to paying for the Interim 2


Kiwi